Literature DB >> 19287505

Understanding the transition to acute illness: the promise of perioperative genomics.

Aslan T Turer1, Debra A Schwinn.   

Abstract

Over the last decades, tremendous advances have been made in understanding the genomic basis of a large number of chronic human diseases. Such advances were made possible by studying large numbers of patients over relatively long periods of time. It is increasingly recognized that acute robust stress stimulates pathways activated in chronic disease, facilitating mechanistic studies in much shorter time frames. A new field of molecular medicine, called perioperative genomics, uses robust surgical stress as a perturbation designed to explore such mechanisms. This new field is described briefly below.

Entities:  

Keywords:  Acute Disease; Genomics; Perioperative Care; Postoperative Complications; Risk Assessment

Mesh:

Year:  2008        PMID: 19287505      PMCID: PMC2654763          DOI: 10.1007/s12265-008-9018-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  9 in total

1.  Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair.

Authors:  Robert J Feezor; Henry V Baker; Wenzhong Xiao; W Anthony Lee; Thomas S Huber; Michael Mindrinos; Raymond A Kim; Laurence Ruiz-Taylor; Lyle L Moldawer; Ronald W Davis; James M Seeger
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

Review 2.  Perioperative medicine: NHLBI working group deliberations and recommendations.

Authors:  Dennis T Mangano
Journal:  J Cardiothorac Vasc Anesth       Date:  2004-02       Impact factor: 2.628

3.  Coronary-artery revascularization before elective major vascular surgery.

Authors:  Edward O McFalls; Herbert B Ward; Thomas E Moritz; Steven Goldman; William C Krupski; Fred Littooy; Gordon Pierpont; Steve Santilli; Joseph Rapp; Brack Hattler; Kendrick Shunk; Connie Jaenicke; Lizy Thottapurathu; Nancy Ellis; Domenic J Reda; William G Henderson
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

4.  National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data.

Authors:  Lola J Kozak; Maria F Owings; Margaret J Hall
Journal:  Vital Health Stat 13       Date:  2005-03

5.  Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery.

Authors:  M V Podgoreanu; W D White; R W Morris; J P Mathew; M Stafford-Smith; I J Welsby; H P Grocott; C A Milano; M F Newman; D A Schwinn
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Genetic polymorphisms and the risk of stroke after cardiac surgery.

Authors:  Hilary P Grocott; William D White; Richard W Morris; Mihai V Podgoreanu; Joseph P Mathew; Dahlia M Nielsen; Debra A Schwinn; Mark F Newman
Journal:  Stroke       Date:  2005-07-28       Impact factor: 7.914

7.  Genetic factors contribute to bleeding after cardiac surgery.

Authors:  I J Welsby; M V Podgoreanu; B Phillips-Bute; J P Mathew; P K Smith; M F Newman; D A Schwinn; M Stafford-Smith
Journal:  J Thromb Haemost       Date:  2005-05-09       Impact factor: 5.824

8.  Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery.

Authors:  Mark Stafford-Smith; Mihai Podgoreanu; Madhav Swaminathan; Barbara Phillips-Bute; Joseph P Mathew; Elizabeth H Hauser; Michelle P Winn; Carmelo Milano; Dahlia M Nielsen; Mike Smith; Richard Morris; Mark F Newman; Debra A Schwinn
Journal:  Am J Kidney Dis       Date:  2005-03       Impact factor: 8.860

9.  Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery.

Authors:  Joseph P Mathew; Mihai V Podgoreanu; Hilary P Grocott; William D White; Richard W Morris; Mark Stafford-Smith; G Burkhard Mackensen; Christine S Rinder; James A Blumenthal; Debra A Schwinn; Mark F Newman
Journal:  J Am Coll Cardiol       Date:  2007-04-30       Impact factor: 24.094

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.